Figures and facts

Vita 34 AG is Germany’s oldest and biggest bank for blood of the umbilical cord for private use. The company, which was founded in 1997 as a limited company, has been a joint-stock company since 2002.

About Vita 34

Established in April 1997
Head office and an own stem cell laboratory in Leipzig
138 employees (status 03/2011)
more than 85,000 stored blood of the umbilical cord preparations (status 03/2011)
revenues: EUR 16.9 million (2010)
19 applications of stored blood of the umbilical cord in children
Business activities: recovery, preparation, long-term storage of blood and stem cell products for the treatment of various disease patterns

Research initiatives

University of Leipzig and IKP Gatersleben:
Dr Michael Cross and Prof Anna Wobus
"Differentiation of stem cells from the blood of the umbilical cord"
Fraunhofer Institute for Cell Therapie and Immunology
Prof Frank Emmerich and Dr Johannes Boltze
"Stroke treatment" and "The therapeutic effectiveness of adult stem cells depending on the age of the cell population and the recipient organism"
Translational Centre for Regenerative Medicine, Leipzig:
Dr Rüdiger Alt
„Establishment and evaluation of VSEL stem cells for tissue repair“
University of Leipzig:
Dr Manja Kamprad
"Proliferation of stem cells from the blood of the umbilical cord"
University of Rostock:
Prof Gustav Steinhoff
"Heart attack treatment"
Technical University of Munich:
Prof Annette-Gabriele Ziegler
"Treatment of diabetes type 1"
Hannover Medical School
Prof Dr Ulrich Martin
"Endothelial umbilical cord blood cells for the production of induced pluripotent stem cells (iPS cells)"

Board of Directors

Dr Eberhard Lampeter, CEO
Degreed Industrial Engineer Jörg Ulbrich, CFO

Supervisory Board

Dr Holger Födisch (Chairman)
Richard J. Neeson (Vice Chairman)
Dr Uwe Marx

Scientific Advisory Board

Prof. Dr med Dr h.c.mult. Wolfgang Holzgreve, MBA
(Wissenschaftskolleg zu Berlin, Institute for Advanced Study)
Prof Eckart Wunder
(Head of the Laboratory for Stem Cell Research at the Institute for Haematological Research of the CHM-Hôpital du Hasenrain in Mulhouse, France)
Prof Dr med Gustav Steinhoff
(Director of the Clinic and Policlinic for Heart Surgery, Medical Faculty of Rostock)

Disclaimer